Eubel Brady & Suttman Asset Management’s Eli Lilly LLY Stock Holding History

Eubel Brady & Suttman Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.14M	Buy	2,616 +2,374	+981%	+$2.43M	0.37%	46
2026 Q1	$223K	Hold	242	–	–	0.03%	108
2025 Q4	$260K	Buy	+242	New	+$231K	0.03%	106
2024 Q3	–	Sell	-255	Closed	-$231K	–	95
2024 Q2	$231K	Buy	+255	New	+$204K	0.03%	87
2016 Q1	–	Sell	-3,497	Closed	-$295K	–	79
2015 Q4	$295K	Hold	3,497	–	–	0.1%	65
2015 Q3	$293K	Hold	3,497	–	–	0.1%	61
2015 Q2	$292K	Sell	3,497 -764	-18%	-$58.2K	0.1%	63
2015 Q1	$310K	Hold	4,261	–	–	0.09%	61
2014 Q4	$294K	Buy	4,261 +411	+11%	+$27.7K	0.09%	61
2014 Q3	$250K	Buy	3,850 +130	+3%	+$8.23K	0.07%	72
2014 Q2	$231K	Buy	+3,720	New	+$222K	0.07%	73

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Eubel Brady & Suttman Asset Management's LLY Position: Q2 2026 in Review

Eubel Brady & Suttman Asset Management increased its Eli Lilly (LLY) stake by 981% in Q2 2026, buying an estimated $2.43M and bringing the position to 2,616 shares worth $3.14M. The position accounts for 0.37% of the portfolio, ranked #46.

Eubel Brady & Suttman Asset Management first reported a position in LLY in Q2 2014 and has held it in 11 quarters since. 4,628 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Eubel Brady & Suttman Asset Management held 2,616 shares of Eli Lilly worth $3.14M as of Q2 2026.
Eubel Brady & Suttman Asset Management bought 2,374 Eli Lilly shares in Q2 2026, an estimated $2.43M.
Eli Lilly made up 0.37% of Eubel Brady & Suttman Asset Management's portfolio in Q2 2026, its #46 holding.
Eubel Brady & Suttman Asset Management first reported a position in Eli Lilly in Q2 2014 and has held it in 11 quarters since.
4,628 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.